DaVita (NYSE:DVA) Upgraded at Wall Street Zen

DaVita (NYSE:DVA) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

DVA has been the topic of several other reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of DaVita in a research report on Monday, December 29th. TD Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 3rd. Barclays lifted their target price on shares of DaVita from $143.00 to $158.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Zacks Research upgraded shares of DaVita from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 4th. Finally, Truist Financial set a $158.00 price objective on shares of DaVita in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $155.80.

DaVita Stock Performance

DVA stock opened at $150.89 on Friday. The firm has a 50 day simple moving average of $120.72 and a 200 day simple moving average of $125.28. DaVita has a 52 week low of $101.00 and a 52 week high of $157.12. The stock has a market cap of $10.08 billion, a P/E ratio of 15.23, a P/E/G ratio of 0.51 and a beta of 0.99.

DaVita (NYSE:DVA) last released its earnings results on Monday, February 2nd. The company reported $3.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.24 by $0.16. DaVita had a net margin of 5.47% and a negative return on equity of 413.18%. The company had revenue of $3.62 billion during the quarter, compared to the consensus estimate of $3.51 billion. During the same quarter in the prior year, the firm earned $2.24 EPS. The company’s revenue was up 9.9% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. Sell-side analysts predict that DaVita will post 10.76 EPS for the current year.

Institutional Trading of DaVita

Large investors have recently modified their holdings of the company. National Pension Service bought a new stake in DaVita during the 3rd quarter valued at approximately $1,305,000. Todd Asset Management LLC acquired a new position in shares of DaVita during the third quarter worth approximately $21,842,000. Assenagon Asset Management S.A. boosted its position in shares of DaVita by 1,951.8% in the third quarter. Assenagon Asset Management S.A. now owns 68,408 shares of the company’s stock valued at $9,089,000 after acquiring an additional 65,074 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of DaVita by 175.1% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,409 shares of the company’s stock worth $2,446,000 after acquiring an additional 11,718 shares during the last quarter. Finally, Rakuten Investment Management Inc. bought a new position in DaVita during the third quarter worth $19,875,000. 90.12% of the stock is owned by institutional investors.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.